| CAPR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CAPR shares outstanding history going back to 11/21/2013:
Also see: CAPR Market Cap History CAPR YTD Return |
CAPR Shares Outstanding History — Capricor Therapeutics Share Count Over Time
As of 5/11/2026 Capricor Therapeutics has 57.91 million CAPR shares outstanding. Investors often track the CAPR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CAPR share count trends over time, with 53 historical shares outstanding datapoints presented, dating back to 11/21/2013.
| CAPR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CAPR Historical Shares Outstanding: +68.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CAPR Stock Price Chart |
| About Capricor Therapeutics Inc |
| Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. Co.'s program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy (DMD). We show 53 historical shares outstanding datapoints in our coverage of CAPR's shares outstanding history. Understanding the changing numbers of CAPR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CAPR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CAPR by allowing them to research CAPR shares outstanding history as well as any other stock in our coverage universe. |
| CAPR Current Stock Quote |
Quotes delayed 20 minutes  Free CAPR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CAPR Share Performance |
| Shares Outstanding Peers |
| Capricor Therapeutics (CAPR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CARA Shares Outstanding History CARM Shares Outstanding History CASI Shares Outstanding History CASM Shares Outstanding History CATB Shares Outstanding History CATS Shares Outstanding History CBAY Shares Outstanding History CBIO Shares Outstanding History CBLI Shares Outstanding History CBM Shares Outstanding History More Healthcare companies » |
CAPR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
